Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matt Kalaycio

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphomaAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.
British Journal of Haematology|February 4, 2020
Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myelomaDiana Basali, Rajshekhar Chakraborty, Lisa Rybicki, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 17, 2013
Ribosomal S6 kinase and AKT phosphorylation as pharmacodynamic biomarkers in patients with myelodysplastic syndrome treated with RAD001Anjali S Advani, Reda Z Mahfouz, Jaroslaw Maciejewski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Vitamin D level after allogeneic hematopoietic stem cell transplantLisa Sproat, Brian Bolwell, Lisa Rybicki, et al.
British Journal of Haematology|June 11, 2009
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantationAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.
Bone Marrow Transplantation|August 1, 2025
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudilVictoria Stepanyants, Hong Li, Danielle Cenin, et al.
Leukemia Research|August 11, 2010
Race and intensity of post-remission therapy in acute myeloid leukemiaAnna K Brady, Alex Z Fu, Marc Earl, et al.
Transplantation and Cellular Therapy|April 1, 2023
A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-DiseaseSagar S Patel, Sanghee Hong, Lisa Rybicki, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 25, 2011
Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotypeRonald M Sobecks, Medhat Askar, Dawn Thomas, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 2, 2015
Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasmsEmir C Roach, Margaret M Park, W H Wilson Tang, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 23, 2008
Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphomaAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.
British Journal of Haematology|February 4, 2020
Real-world data on safety and efficacy of venetoclax-based regimens in relapsed/refractory t(11;14) multiple myelomaDiana Basali, Rajshekhar Chakraborty, Lisa Rybicki, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 17, 2013
Ribosomal S6 kinase and AKT phosphorylation as pharmacodynamic biomarkers in patients with myelodysplastic syndrome treated with RAD001Anjali S Advani, Reda Z Mahfouz, Jaroslaw Maciejewski, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 4, 2011
Vitamin D level after allogeneic hematopoietic stem cell transplantLisa Sproat, Brian Bolwell, Lisa Rybicki, et al.
British Journal of Haematology|June 11, 2009
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantationAnuj Mahindra, Brian Bolwell, Ronald Sobecks, et al.
Bone Marrow Transplantation|August 1, 2025
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudilVictoria Stepanyants, Hong Li, Danielle Cenin, et al.
Leukemia Research|August 11, 2010
Race and intensity of post-remission therapy in acute myeloid leukemiaAnna K Brady, Alex Z Fu, Marc Earl, et al.
Transplantation and Cellular Therapy|April 1, 2023
A Pilot Trial of Patient-Reported Outcomes for Acute Graft-Versus-Host-DiseaseSagar S Patel, Sanghee Hong, Lisa Rybicki, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|May 25, 2011
Cytomegalovirus reactivation after matched sibling donor reduced-intensity conditioning allogeneic hematopoietic stem cell transplant correlates with donor killer immunoglobulin-like receptor genotypeRonald M Sobecks, Medhat Askar, Dawn Thomas, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 2, 2015
Impaired right ventricular-pulmonary vascular function in myeloproliferative neoplasmsEmir C Roach, Margaret M Park, W H Wilson Tang, et al.
Pageof 16